Changes in the treatment strategy following intracoronary pressure wire in a contemporaneous real-life cohort of patients with intermediate coronary stenosis. Results from a nationwide registry.

Fecha de publicación: 03/02/2023 Fecha Ahead of Print: 03/02/2023

Autores de IIS La Fe

• José Luis Díez Gil

  Autor

Participantes ajenos a IIS La Fe

• Rodriguez-Leor, Oriol
• Toledano, Beatriz
• Lopez-Palop, Ramon
• Rivero, Fernando
• Brugaletta, Salvatore
• Linares, Jose Antonio
• Benito, Tomas
• Carrillo, Pilar
• Puigfel, Marti
• Cediel, German
• Sadaba, Mario
• Vaquerizo, Beatriz
• Rondan, Juan
• Gomez, Ivan
• Alfonso, Fernando
• Saez, Roberto
• Planas, Ana
• Lozano, Fernando
• Hernandez, Felipe
• Sabate, Manel
• Ruiz-Arroyo, Jose Ramoen
• Torres, Francisco
• de la Torre Hernandez, Jose Maria
• Gutierrez, Enrique
• Cid-Alvarez, Ana Belen
• Fernandez, Luis
• Moreu, Jose
• Ojeda, Soledad
• Cerrato, Pablo
• Ruiz-Quevedo, Valeriano
• Sanchis, Juan
• Gomez-Menchero, Antonio
• Ocaranza, Raymundo
• Mohandes, Mohsen
• Hernandez, Jose Maria
• Alfageme, Miren Maite
• Aguiar, Pablo
• Lopez Minguez, Jose Ramon
• Perez de Prado, Armando
• REGIPRES investigators

Grupos

• Grupo de Investigación Clínica y Traslacional en Cardiología

  

  Investigador Principal

  Esther Roselló Lletí

Abstract

BACKGROUND: Intracoronary pressure wire is useful to guide revascularization in patients with coronary artery disease. AIMS: To evaluate changes in diagnosis (coronary artery disease extent), treatment strategy and clinical results after intracoronary pressure wire study in real-life patients with intermediate coronary artery stenosis. METHODS: Observational, prospective and multicenter registry of patients in whom pressure wire was performed. The extent of coronary artery disease and the treatment strategy based on clinical and angiographic criteria were recorded before and after intracoronary pressure wire guidance. 12-month incidence of MACE (cardiovascular death, non-fatal myocardial infarction or new revascularization of the target lesion) was assessed. RESULTS: 1414 patients with 1781 lesions were included. Complications related to the procedure were reported in 42 patients (3.0 %). The extent of coronary artery disease changed in 771 patients (54.5 %). There was a change in treatment strategy in 779 patients (55.1 %) (18.0 % if medical treatment; 68.8 % if PCI; 58.9 % if surgery (p < 0.001 for PCI vs medical treatment; p = 0.041 for PCI vs CABG; p < 0.001 for medical treatment vs CABG)). In patients with PCI as the initial strategy, the change in strategy was associated with a lower rate of MACE (4.6 % vs 8.2 %, p = 0.034). CONCLUSIONS: The use of intracoronary pressure wire was safe and led to the reclassification of the extent of coronary disease and change in the treatment strategy in more than half of the cases, especially in patients with PCI as initial treatment.

Copyright © 2023 Elsevier Inc. All rights reserved.

Keywords

• Coronary artery disease; FFR; Non-hyperemic diastolic indices; Pressure wire; Registry